Description
InformationRG3039 RG3039 (PF-06687859, PF 6687859, Quinazoline 495) is an orally bioavailable and brain-penetrant inhibitor of the mRNA decapping enzyme DcpS with IC50 of 4.2 nM and IC90 of 40 nM, respectively.TargetsDcpS (Cell-free assay); DcpS (Cell-free assay) 4.2 nM; 40 nM(IC90)